-
Duality Biologics divulges new trabectedin derivatives
04 Sep 2025 22:13 GMT
-
FAU's Amy Wright, Ph.D., Honored for Marine Drug Discovery Research
04 Sep 2025 14:27 GMT
… medicines. It promotes research and collaboration to help discover new drugs … of Trabectedin (Yondelis™), an FDA-approved drug used … which selectively targets cancer cells with specific … , many with significant pharmaceutical potential,” said Wright. …
-
Fallopian Tube Cancer Pipeline Outlook Report 2025: Key 70+ Companies And Breakthrough Therapies Shaping The Future Landscape
13 Aug 2025 00:34 GMT
… Jiangsu HengRui Medicine, Advenchen … pharmaceutical market-access the full report today!" @ Fallopian Tube Cancer Clinical Trials … Drug Administration (FDA) for the treatment of certain types of cancers … Cancer Pipeline Therapies- Bevacizumab, Trabectedin …
-
Sonnet BioTherapeutics Expands Clinical Evaluation of SON-1010 Dose Escalation with Atezolizumab in Ovarian Cancer
04 Aug 2025 12:40 GMT
… -1010 alternating with trabectedin (Yondelis®) in patients … biotechnology company with a proprietary platform for developing targeted biologic drugs … peptides, antibodies and vaccines. Sonnet’s lead … for the treatment of pancreatic cancer. Forward-Looking …
-
What dinosaur fossils could teach us about cancer
16 Jun 2025 16:19 GMT
… diseases like cancer, that affected dinosaurs.
Cancer’s deep … plants or trees. The drug trabectedin, for example, used to … we can identify cancer-suppressing or cancer-promoting proteins in … detail, tracking how cancer mechanisms evolved over millions …
-
The medicines that lie beneath
02 Jun 2025 05:42 GMT
… , marine biotechnologist at the … pharmaceutical company called Burroughs Wellcome funded a clinical trial to evaluate the drug … Drug Administration (FDA) for treating AIDS. Further clinical trials … medication used in the treatment of patients with breast cancer …
-
CellCentric Completes $120 Million Series C Funding Round for Multiple Myeloma Treatment Inobrodib
22 May 2025 00:26 GMT
… multiple myeloma patients.
Planned trials include phase II… UK-based clinical-stage biotechnology company, for the advancement … a trabectedin generic, from Accord Healthcare, for treatment of … ;CBP Bromodomain Inhibitor CCS1477. Cancer.gov (accessed May 20, …
-
Peritoneal Cancer Pipeline Appears Robust With 55+ Key Pharma Companies Actively Working In The Therapeutics Segment | Delveinsight
21 May 2025 02:35 GMT
… trials, emerging therapies, and leading companies with DelveInsight @ Peritoneal Cancer Treatment Drugs
Peritoneal Cancer Emerging Drugs … its clinical trial for the treatment of peritoneal cancer.
Azenosertib: Zentalis Pharmaceuticals
Azenosertib is …
-
Moleculin Announces New Pre-Clinical Data for Annamycin Demonstrating Market Expansion Potential Including Treatment for Pancreatic Cancer
29 Apr 2025 12:35 GMT
… , Gemcitabine, Ifosfamide, Trabectedin, or Vincristine to … .03. Drug Combination Strategies for Cancer Treatment
Abstract Number … , Division of Cancer Medicine, The University … Biotech, Inc. Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical …
-
Moleculin Announces Acceptance of Abstract to be Presented at the American Association for Cancer Research (AACR) Annual Meeting 2025
17 Apr 2025 12:30 GMT
… , Gemcitabine, Ifosfamide, Trabectedin, or Vincristine to … .03. Drug Combination Strategies for Cancer Treatment
Abstract Number … of Cancer Medicine, MD Anderson Cancer Center
… Biotech, Inc. Moleculin Biotech, Inc. is a Phase 3 clinical stage pharmaceutical …
About
© 1995-2025